Author

M. d. C. Jaeger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cancer & tumor microenvironment· 3 Research Focus:differential expression· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2

Frequent Co-Authors

A. L. Brunetto· 3 shared A. T. Brunetto· 3 shared C. B. de Farias· 3 shared R. Roesler· 3 shared C. Nor· 2 shared M. D. Taylor· 2 shared V. Ramaswamy· 2 shared A. L. Herlinger· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. L. Brunetto

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR

A. L. Herlinger, G. L. Michaelsen, M. Sinigaglia, L. Fratini, G. N. Debom, E. Braganhol, C. B. de Farias, A. L. Brunetto, A. T. Brunetto, M. d. C. Jaeger, R. Roesler

This study shows rosmarinic acid reduces proliferation and stemness in medulloblastoma cells by targeting HDAC1, EGFR, and ERK signaling, and increasing p21 expression.

bioRxiv · Aug 10, 2023Cancer Biology

HDAC and MAPK/ERK inhibitors cooperate to reduce viability and stemness phenotype in medulloblastoma

M. d. C. Jaeger, E. C. Ghisleni, P. S. Cardoso, M. Siniglaglia, T. Falcon, A. T. Brunetto, A. L. Brunetto, C. B. de Farias, M. D. Taylor, C. Nor, V. Ramaswamy, R. Roesler

This study shows that combining HDAC and MAPK/ERK inhibitors reduces medulloblastoma cell viability and stemness by modulating chromatin state and signaling pathways.

bioRxiv · Jan 30, 2020Cancer Biology

Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma

A. Thomaz, K. d. V. Pinheiro, B. K. Souza, L. Gregianin, A. L. Brunetto, A. T. Brunetto, C. B. de Farias, M. d. C. Jaeger, V. Ramaswamy, C. Nor, M. D. Taylor, R. Roesler

This study shows that TrkB inhibition with ANA-12 reduces medulloblastoma cell proliferation, increases apoptosis, and induces differentiation markers.

bioRxiv · May 28, 2019Cancer Biology